Published 3 days ago • loading... • Updated 2 days ago

What's Going On With IonQ Shares Monday? - IonQ (NYSE:IONQ)

Summary by Benzinga

IonQ shares traded higher Monday after the company announced results of a collaborative research program with AstraZeneca, Amazon Web Services and Nvidia.

8 Articles

All

Left

Center

Right

ilgiornale.it

Lean Right

IonQ Speeds up the Application of Drug Development Accelerated by Quantum Technology with AstraZeneca, AWS and NVIDIA

IonQ speeds up the application of drug development accelerated by quantum technology with AstraZeneca, AWS and NVIDIA

2 days ago·Italy

Read Full Article

Benzinga

Center

What's Going On With IonQ Shares Monday? - IonQ (NYSE:IONQ)

IonQ shares traded higher Monday after the company announced results of a collaborative research program with AstraZeneca, Amazon Web Services and Nvidia.

3 days ago·New York, United States

Read Full Article

Seeking Alpha

Lean Right

IonQ, AstraZeneca, Nvidia and AWS show quantum-accelerated drug development workflow

IonQ (IONQ) announced results of a research program between the company, AstraZeneca (AZN), Amazon Web Services (AMZN) and Nvidia (NVDA).

3 days ago·United States

Read Full Article

quantumzeitgeist.com

Quantum Computing Accelerates Drug Discovery: 20x Speedup Achieved By IonQ, AstraZeneca & AWS

A collaborative effort between IonQ, AstraZeneca, AWS, and NVIDIA has achieved a 20-fold acceleration in simulating a Suzuki-Miyaura reaction—a crucial step in small molecule drug synthesis—by integrating IonQ’s Forte quantum processing unit with NVIDIA’s CUDA-Q platform via Amazon Braket

2 days ago

Read Full Article

01net

Summary: IonQ Accelerates Quantum-Accelerated Drug Development Application with AstraZeneca, AWS, and NVIDIA

Largest demonstration of its kind integrates leading hardware, platforms and technologies to achieve 20x acceleration over previous demonstrations The collaboration across ecosystems also marks a major step... The article Summary: IonQ Accelerates Quantum-Accelerated Drug Development Application with AstraZeneca, AWS and NVIDIA is an original content from 01net.

2 days ago

Read Full Article

insidermonkey.com

IonQ, Inc. (IONQ): Jim Cramer Says He ‘Cannot Recommend That Stock’

On Monday, Jim Cramer of Mad Money took a closer look at the market’s recent movements, reassuring investors that rising bond yields shouldn’t cause excessive worry.

2 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year